Does Meningioma Volume Correlate With Clinical Disease Manifestation Irrespective of Histopathologic Tumor Grade?


Journal

The Journal of craniofacial surgery
ISSN: 1536-3732
Titre abrégé: J Craniofac Surg
Pays: United States
ID NLM: 9010410

Informations de publication

Date de publication:
Historique:
pubmed: 22 10 2019
medline: 11 1 2020
entrez: 22 10 2019
Statut: ppublish

Résumé

The aim of the study was to investigate the association between meningioma volume and the occurrence of clinic-radiologic signs of tumor aggressiveness. For volumetric approximation, the authors evaluated the method of semiautomatic image segmentation at hand of high-resolution MRI-image sequences. ITK-SNAP was utilized for semiautomatic image segmentation of 58 gadolinium-contrast enhanced T1-weighted thin-slice MRI datasets for volumetric analysis. Furthermore, multimodal imaging datasets (including T2, FLAIR, T1) were evaluated for radiological biomarkers of aggressiveness and growth potential. Thereby generated data was checked for association with retrospectively collected data points. Location (P = 0.001), clinical disease manifestation (P = 0.033), peritumoral edema (P = 0.038), tumor intrinsic cystic degeneration (P = 0.007), three-dimensional complexity (P = 0.022), and the presence of meningioma mass effect (P = 0.001) were statistically associated with higher tumor volumes. There was no association between higher tumor volumes and histopathological tumor grade. The size of a meningioma does not seem to reliably predict tumor grade. Growth potential seems to be influenced by tumor location. Higher tumor volumes were significantly associated with the occurrence of clinical symptoms.

Identifiants

pubmed: 31633669
doi: 10.1097/SCS.0000000000005845
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e799-e802

Auteurs

Martin Kauke (M)

Harvard Medical School, Boston, MA.
Department of General Neurosurgery, Center for Neurosurgery, University Hospital Cologne, Cologne, Germany.

Ali-Farid Safi (AF)

Harvard Medical School, Boston, MA.

Pantelis Stavrinou (P)

Department of General Neurosurgery, Center for Neurosurgery, University Hospital Cologne, Cologne, Germany.

Boris Krischek (B)

Department of General Neurosurgery, Center for Neurosurgery, University Hospital Cologne, Cologne, Germany.

Roland Goldbrunner (R)

Department of General Neurosurgery, Center for Neurosurgery, University Hospital Cologne, Cologne, Germany.

Marco Timmer (M)

Department of General Neurosurgery, Center for Neurosurgery, University Hospital Cologne, Cologne, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH